This study will collect demographic and safety information on the use of ROTATEQ™ in the Philippines.
Study Type
OBSERVATIONAL
Enrollment
915
Number of participants with adverse events following administration of ROTATEQ™
Time frame: Three-year period following vaccine marketing approval (August 2007 to August 2010)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.